These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5694266)

  • 1. Effect of prenylamine on locomotor activity and brain monoamine levels in mice.
    Ahtee L; Kärki N
    Acta Pharmacol Toxicol (Copenh); 1968; 26(1):55-63. PubMed ID: 5694266
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of reserpine, alpha-methyl-m-tyrosine, prenylamine, and guanethidine on metrazol-convulsions and the brain monoamine level in mice.
    Pfeifer AK; Galambos E
    Arch Int Pharmacodyn Ther; 1967 Jan; 165(1):201-11. PubMed ID: 6030237
    [No Abstract]   [Full Text] [Related]  

  • 3. Locomotor activity and regional brain noradrenaline levels in rats treated with prenylamine.
    Broitman ST; Donoso AO
    Experientia; 1971; 27(11):1308-9. PubMed ID: 5134289
    [No Abstract]   [Full Text] [Related]  

  • 4. Brain levels of serotonin (5-HT) and norepinephrine (NE) during mescaline-induced behavior in mice.
    Shah NS
    Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):201-4. PubMed ID: 4686103
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of three dihydroxylated derivatives of tryptamine on the behavior and on brain amine content in mice.
    Massotti M; Scotti de Carolis A; Longo VG
    Pharmacol Biochem Behav; 1974; 2(6):769-76. PubMed ID: 4549398
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of 4-chlorophenoxyamphetamine (A-6587), d-amphetamine and 4-chloroamphetamine on brain biogenic amines and behavior in mice.
    Everett GM; Yellin TO
    Res Commun Chem Pathol Pharmacol; 1971; 2(4):407-13. PubMed ID: 4400361
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of a central stimulant substance isolated from the sea anemone Stoichactis kenti on brain monoamines of the mouse.
    Turlapaty P; Shibata S; Norton TR; Kuchii M
    Eur J Pharmacol; 1973 Dec; 24(3):359-65. PubMed ID: 4148845
    [No Abstract]   [Full Text] [Related]  

  • 8. Some actions of pentazocine on behavior and brain monoamines in the rat.
    Holtzman SG; Jewett RE
    J Pharmacol Exp Ther; 1972 May; 181(2):346-56. PubMed ID: 5030675
    [No Abstract]   [Full Text] [Related]  

  • 9. Some agonistic actions of the morphone antagonist levallorphan on behavior and brain monoamines in the rat.
    Steinert HR; Holtzman SG; Jewett RE
    Psychopharmacologia; 1973 Jul; 31(1):35-48. PubMed ID: 4721474
    [No Abstract]   [Full Text] [Related]  

  • 10. Behavior and biochemical effects of preferentially protecting monoamines in the brain against the action of reserpine.
    Butcher LL; Rhodes DL; Yuwiler A
    Eur J Pharmacol; 1972 May; 18(2):204-12. PubMed ID: 4537669
    [No Abstract]   [Full Text] [Related]  

  • 11. L-Dopa and imipramine: biochemical and behavioral interaction.
    Friedman E; Gershon S
    Eur J Pharmacol; 1972 May; 18(2):183-8. PubMed ID: 5037381
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of catecholamines in the central effects of amphetamine.
    Pfeifer AK; György L; Fodor M
    Acta Med Acad Sci Hung; 1968; 25(3):441-50. PubMed ID: 5720870
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of early post-natal alpha-methyl-dopa treatment on behavior in the rat.
    Juvancz P; Nowaczyk T
    Psychopharmacologia; 1975 Apr; 42(1):95-7. PubMed ID: 168606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quipazine, a new type of antidepressant agent.
    Rodríguez R; Pardo EG
    Psychopharmacologia; 1971; 21(1):89-100. PubMed ID: 5567294
    [No Abstract]   [Full Text] [Related]  

  • 15. Delta9-tetrahydrocannabinol induced inhibition of predatory aggression in the rat.
    Kilbey MM; Moore JW
    Psychopharmacologia; 1973 Jul; 31(2):157-66. PubMed ID: 4737311
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of brain amines in the behavioral depression produced by a benzoquinolizine.
    Miller FP; Maickel RP
    Life Sci; 1969 May; 8(9):487-91. PubMed ID: 5791701
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of acylation with eleostearic acids on the monoamine oxidase inhibitory potency of some hydrazine antidepressants in mice.
    Hsu SY; Huang CL; Waters IW
    J Med Chem; 1975 Jan; 18(1):20-3. PubMed ID: 1109570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of L-dopa on the locomotor activity of rats pretreated with 6-hydroxydopamine.
    Uretsky NJ; Schoenfeld RI
    Nat New Biol; 1971 Dec; 234(48):157-9. PubMed ID: 5289320
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of the effects of D-amphetamine and L-amphetamine in reversing depression of mouse locomotor activity caused by reserpine.
    Proctor CD; Kirby J; Wood MH; Wade LH; King PK
    Arch Int Pharmacodyn Ther; 1974 Nov; 212(1):108-15. PubMed ID: 4451411
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential effects of monoamine oxidase inhibitors.
    Maickel RP; Rompalo AM; Cox RH
    Res Commun Chem Pathol Pharmacol; 1974 Aug; 8(4):727-30. PubMed ID: 4420181
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.